Pharmacogenomics : social, ethical, and clinical dimensions / edited by Mark A. Rothstein.

Date:
[2003], ©2003
  • Books

About this work

Publication/Creation

Hoboken, N.J. : Wiley-Liss, [2003], ©2003.

Physical description

xii, 368 pages : illustrations ; 24 cm

Contributors

Contents

Public attitudes about pharmacogenomics / Mark A. Rothstein and Carlton A. Hornung -- Pharmacogenomics: pharmacology and toxicology in the genomics era / Harvey W. Mohrenweiser -- The implications of population genetics for pharmacogenomics / Craig L. Hanis -- Genome research and minorities / Henry T. Greely -- Drug development strategies / Penelope K. Manasco and Teresa E. Arledge -- Drug development, regulation, and genetically guided therapy / David W. Feigal and Steven I. Gutman -- Intellectual property and commercial aspects of pharmacogenomics / Allen C. Nunnally, Scott A. Brown, and Gary A. Cohen -- Integration of pharmacogenomics into medical practice / Gilbert S. Omenn and Arno G. Motulsky -- Clinical utility of pharmacogenetics and pharmacogenomics / Neil A. Holtzman -- Medical liability for pharmacogenomics -- Larry I. Palmer -- The challenges of pharmacogenomics for pharmacy education / David B. Brushwood -- Economic implications of pharmacogenomics / C.E. Reeder and W. Michael Dickson -- Pharmacogenomics and the social construction of identity / Morris W. Foster -- Pharmacogenomics: considerations for communities of color / Laurie Nsiah-Jefferson -- Constitutional issues in the use of pharmacogenomic variations associated with race / John A. Robertson.

Bibliographic information

Includes bibliographical references and index.

Languages

Where to find it

  • LocationStatus
    Medical Collection
    QV38 2003P53
    Open shelves

Permanent link

Identifiers

ISBN

  • 0471227692